320 reports of this reaction
2.0% of all FAM TRASTUZUMAB DERUXTECAN NXKI reports
#11 most reported adverse reaction
NO ADVERSE EVENT is the #11 most commonly reported adverse reaction for FAM TRASTUZUMAB DERUXTECAN NXKI, manufactured by Daiichi Sankyo Inc.. There are 320 FDA adverse event reports linking FAM TRASTUZUMAB DERUXTECAN NXKI to NO ADVERSE EVENT. This represents approximately 2.0% of all 15,771 adverse event reports for this drug.
Patients taking FAM TRASTUZUMAB DERUXTECAN NXKI who experience no adverse event should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NO ADVERSE EVENT is a less commonly reported adverse event for FAM TRASTUZUMAB DERUXTECAN NXKI, but still significant enough to appear in the safety profile.
In addition to no adverse event, the following adverse reactions have been reported for FAM TRASTUZUMAB DERUXTECAN NXKI:
The following drugs have also been linked to no adverse event in FDA adverse event reports:
NO ADVERSE EVENT has been reported as an adverse event in 320 FDA reports for FAM TRASTUZUMAB DERUXTECAN NXKI. This does not prove causation, but indicates an association observed in post-market surveillance data.
NO ADVERSE EVENT accounts for approximately 2.0% of all adverse event reports for FAM TRASTUZUMAB DERUXTECAN NXKI, making it a notable side effect.
If you experience no adverse event while taking FAM TRASTUZUMAB DERUXTECAN NXKI, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.